EPIPF logo
Epiroc AB (publ)(EPIPF)
Closing price · checked 10:29 PM ETAbout this dataData status
$23.10▲0.00 (0.00%)
Extended:$23.10+0.00 (+0.00%)· 10:29 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Epiroc AB (publ) (EPIPF)

Operating Expenses

kr 9.94B

TTM · Period ending: · SEK

EPIPF logo

EPIPF Operating Expenses

Latest reportedkr 9.94B SEK
EPIPF Operating Expenses · SEK (kr 5.05B → kr 9.94B)
High-resolution chart · PNG

What is operating expenses?

Expenses from normal business operations (SG&A, R&D, etc.).

EPIPF operating expenses history

Annual fiscal periods · SEK. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Epiroc AB (publ) Operating Expenses — Annual fiscal periods (SEK)
Period endingOperating Expenses (SEK)Change
10,285,000,000−2.61%
10,561,000,000+6.00%
9,963,000,000+22.89%
8,107,000,000+21.00%
6,700,000,000+10.09%
6,086,000,000−15.24%
7,180,000,000+10.51%
6,497,000,000+25.42%
5,180,000,000+10.24%
4,699,000,000−6.90%
5,047,000,000—

Frequently asked questions: EPIPF operating expenses

What is Epiroc AB (publ) (EPIPF)'s current operating expenses?

Epiroc AB (publ) (EPIPF)'s latest reported operating expenses (TTM) is kr 9.94B as of Sep 30, 2026. Expenses from normal business operations (SG&A, R&D, etc.).

How much historical operating expenses data is available for EPIPF?

Stock Alarm Pro provides 11 dated annual fiscal periods observations for Epiroc AB (publ) (EPIPF)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare EPIPF's operating expenses to peers or set an alert?

You can open EPIPF's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on EPIPF delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.